BAJAJ BROKING

Notification close image
No new Notification messages
card image
Travel Food Services IPO is Open!
Apply for the Travel Food Services IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

24350

0

NEPHROCARE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

NEPHRO CARE INDIA LIMITED performance

Today’s low

Today’s high

₹ 115.00 ₹ 120.05
₹ 118.45

52 week low

52 week high

₹ 115.00 ₹ 378.80
₹ 118.45

Open Price

₹ 120.05

Prev. Close

₹ 123.15

Volume (Shares)

46400.00

Total traded value

₹ 54.96

Upper Circuit

₹ 147.75

Lower Circuit

₹ 98.55

info

NEPHRO CARE INDIA LIMITED Share Price Update

As of the latest trading session, NEPHRO CARE INDIA LIMITED share price is currently at ₹ 117.15, which is down by ₹ -6.00 from its previous closing. Today, the stock has fluctuated between ₹ 115.00 and ₹ 120.05. Over the past year, NEPHRO CARE INDIA LIMITED has achieved a return of -34.02 %. In the last month alone, the return has been -13.91 %. Read More...

Investment Returns

Over 1 Month -13.91% Over 3 Months -20.07% Over 6 Months -36.41% Over 1 Year -34.02%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

NEPHRO CARE INDIA LIMITED fundamentals


  • Market cap (Cr)

    195.30

  • P/E Ratio (TTM)

    53.60

  • Beta

    1.21

  • Book Value / share

    32.44

  • Return on equity

    50.26%

  • EPS (TTM)

    2.21

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.01

info icon alternate text
  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

info icon alternate text

NEPHRO CARE INDIA LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 7.48
Operating Expense 0.00
Net Profit 1.01
Net Profit Margin (%) 13.50
Earnings Per Share (EPS) 0.85
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 6.65
Operating Expense 0.00
Net Profit -0.25
Net Profit Margin (%) -3.75
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 46.03
Operating Expense 42.73
Net Profit 3.64
Net Profit Margin (%) 7.90
Earnings Per Share (EPS) 2.38
EBITDA 7.40
Effective Tax Rate (%) 24.63
Particulars MAR 2024 (Values in Cr)
Revenue 27.23
Operating Expense 21.38
Net Profit 4.41
Net Profit Margin (%) 16.19
Earnings Per Share (EPS) 3.80
EBITDA 6.84
Effective Tax Rate (%) 27.65
Particulars MAR 2023 (Values in Cr)
Revenue 17.09
Operating Expense 14.52
Net Profit 2.37
Net Profit Margin (%) 13.86
Earnings Per Share (EPS) 38.85
EBITDA 3.42
Effective Tax Rate (%) 7.75
Particulars MAR 2022 (Values in Cr)
Revenue 3.42
Operating Expense 3.43
Net Profit -0.01
Net Profit Margin (%) -0.29
Earnings Per Share (EPS) -0.20
EBITDA 0.13
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 1.82
Operating Expense 1.71
Net Profit 0.09
Net Profit Margin (%) 4.94
Earnings Per Share (EPS) 88.70
EBITDA 0.16
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 12.62
ROE % 50.26
ROCE % 61.86
Total Debt to Total Equity 0.14
EBITDA Margin 24.47
Particulars MAR 2023 (Values in Cr)
Book Value / Share 50.57
ROE % 156.44
ROCE % 65.51
Total Debt to Total Equity 1.65
EBITDA Margin 18.84
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.90
ROE % -153.85
ROCE % 1.59
Total Debt to Total Equity 6.22
EBITDA Margin 4.09
Particulars MAR 2021 (Values in Cr)
Book Value / Share 15.00
ROE % 450.00
ROCE % 20.83
Total Debt to Total Equity 34.57
EBITDA Margin 8.79
Particulars MAR 2020 (Values in Cr)
Book Value / Share 82.01
ROE % -12.50
ROCE % 6.38
Total Debt to Total Equity 4.88
EBITDA Margin 5.56
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.29
Total Assets 20.96
Total Liabilities 20.96
Total Equity 15.02
Share Outstanding 11902400
Price to Book Ratio 0.00
Return on Assets (%) 21.03
Return on Capital (%) 29.36
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.31
Total Assets 8.25
Total Liabilities 8.25
Total Equity 2.52
Share Outstanding 500000
Price to Book Ratio 0.00
Return on Assets (%) 28.72
Return on Capital (%) 47.35
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.60
Total Assets 4.62
Total Liabilities 4.62
Total Equity 0.49
Share Outstanding 500000
Price to Book Ratio 0.00
Return on Assets (%) -0.21
Return on Capital (%) -0.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.48
Total Assets 1.28
Total Liabilities 1.28
Total Equity 0.21
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 10.53
Return on Capital (%) 14.85
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 0.78
Total Liabilities 0.78
Total Equity 0.08
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) -1.87
Return on Capital (%) -3.11
Particulars MAR 2024 (Values in Cr)
Net Income 6.22
Cash from Operations 3.20
Cash from Investing -7.53
Cash from Financing 5.60
Net change in Cash -1.02
Free Cash Flow 5.63
Particulars MAR 2023 (Values in Cr)
Net Income 2.57
Cash from Operations 4.16
Cash from Investing -2.33
Cash from Financing -0.08
Net change in Cash 1.70
Free Cash Flow 4.66
Particulars MAR 2022 (Values in Cr)
Net Income 0.00
Cash from Operations 0.68
Cash from Investing -2.81
Cash from Financing 2.32
Net change in Cash 0.12
Free Cash Flow 2.13
Particulars MAR 2021 (Values in Cr)
Net Income 0.11
Cash from Operations 0.19
Cash from Investing -0.06
Cash from Financing 0.27
Net change in Cash 0.44
Free Cash Flow 0.26
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTERPRISE LT 7554.30 75.12 13.23 108619.24 6002.15 / 7599.75
FORTIS MALAR HOSPITALS LIMITED 72.99 347.57 4.53 136.80 51.01 / 98.70
SHREE PACETRONIX LTD. 84.74 40.74 2.21 30.50 61.11 / 221.50
TRANSGENE BIOTEK LTD. 4.85 0.00 3.66 36.75 3.22 / 10.84
VIMTA LABS LTD. 470.85 34.47 6.11 2095.54 235.00 / 591.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTERPRISE LT 7554.30 83.79 12.43 108619.24 6002.15 / 7599.75
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 33.06 0.00 -13.06 24.70 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6130.35 32.10 6.17 6706.60 4067.50 / 6400.00

NEPHRO CARE INDIA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
118.45 -3.81 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 121.10
  • 26 Days 126.90
  • 10 Days 122.20
  • 50 Days 132.60
  • 12 Days 122.80
  • 100 Days 145.90
  • 20 Days 125.20
  • 200 Days 181.20
125.38 PIVOT

First Support

119.82

First Resistance

128.72

Second Support

116.48

Second Resistance

134.28

Third Support

110.92

Third Resistance

137.62

RSI

39.04

ADX

40.68

MACD

-4.16

Williams % R

-78.37

Commodity Channel Index (CCI)

-133.17

Date

2025-07-04

Week

21867.00

Same Day

31600.00

Month

13774.00

1 Year

1.21

3 Year

1.22

Over 1 Month

-13.91%

down

Over 1 Year

-34.02%

down

Over 3 Months

-20.07%

down

Over 3 Years

0.00%

down

Over 6 Months

-36.41%

down

Over 5 Years

0.00%

down

NEPHRO CARE INDIA LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
35.05%
Promoter Holdings
61.43%
FII
3.5%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Pratim Sengupta 1.00088E7 (60.71%) Shareholding of Promoter and Promoter Group
Rohan Vinay Pai 369600.0 (2.24%) Public Shareholding
Jagdish Prashad Sharma 320000.0 (1.94%) Public Shareholding
Ark Global Emerging Companies Lp 277200.0 (1.68%) Public Shareholding
Ccv Emerging Opportunities Fund-i 227200.0 (1.38%) Public Shareholding
Shila Sengupta 48000.0 (0.29%) Shareholding of Promoter and Promoter Group
Pradyot Kumar Sengupta 48000.0 (0.29%) Shareholding of Promoter and Promoter Group
Prasenjit Sengupta 24000.0 (0.15%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

NEPHRO CARE INDIA LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

NEPHRO CARE INDIA LIMITED Share Price

Nephro Care India Limited was originally incorporated on July 08, 2014 as a Private Limited Company as 'Nephro Care India Private Limited' with the Registrar of Companies, West Bengal. Subsequently, Company converted into a Public Limited Company and the name of Company was changed to Nephro Care India Limited' and a fresh Certificate of Incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre.

Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients. The Company is a one stop treatment centre based in Kolkata that offer clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.

The main business of the company is to provide comprehensive 360 Degree healthcare servicing to the patients with kidney related services, The Company operate only in non -invasive service, their operations have been supported by a pool of expert Doctors, experienced and well-trained paramedical professionals and a skilled management team. The entire team is further supported by sufficient clinical and investigative infrastructure.

The Company in 2021, started flagship Salt Lake, Kolkata clinic; it started two satellite clinics operations at Chandannagar, in West Bengal in 2023, by taking up a Dialysis unit with e-Age Healthcare. The high cost of dialysis care has led to financial hardship for practically all families with such patients. Apart from this, the clinics have been equipped with technologically advanced equipment and diagnostic instruments.

At present, Nephro Care offers the services at their clinics following Inhouse Dialysis Unit; Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology; NABL accredited inhouse Pathology; Inhouse Pharmacy; Advance diagnostic facilities; Renal Nutrition department; Home Care; Mukti (Lifestyle Support Program) and Home Dialysis. Besides, it has in house diagnostic tools including UGS, ECHO, ECG, X Ray, PFT, NCB, Fibroscan, Sudoscan, Fundoscopy, BCM, Polysomnography, Holter monitoring which ensure complete screening and accurate diagnosis.

Parent organization Indian Private
NSE symbol NEPHROCARE
Founded 2014
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Nephro Care India Ltd?

Answer Field

Nephro Care India Ltd share price is for NSE ₹ 117.15 & for BSE ₹ 0.00 as on Jul 04 2025 03:28 PM.

What is the Market Cap of Nephro Care India Ltd Share?

Answer Field

The market cap of Nephro Care India Ltd for NSE ₹ 195.30 & for BSE ₹ 0.00 as on Jul 04 2025 03:28 PM.

What is the 52 Week High and Low of Nephro Care India Ltd?

Answer Field

The 52 Week High and Low of Nephro Care India Ltd for NSE is ₹ 378.80 and ₹ 115.00 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Nephro Care India Ltd?

Answer Field

The 1 year returns on the stock has been -34.02%.

What is the P/E Ratio of Nephro Care India Ltd Share?

Answer Field

As on Jul 04 2025 03:28 PM the price-to-earnings (PE) ratio for Nephro Care India Ltd share is 53.60.

What is the PB ratio of Nephro Care India Ltd Share?

Answer Field

As on Jul 04 2025 03:28 PM, the price-to-book (PB) ratio for Nephro Care India Ltd share is 32.44.

How to Buy Nephro Care India Ltd Share?

Answer Field

You can trade in Nephro Care India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Nephro Care India Ltd Share on Bajaj Broking App?

Answer Field

To buy Nephro Care India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Nephro Care India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|